Liver Cancer News and Research

RSS

Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.

Research suggests potential new treatment strategy for phenylketonuria

Researchers at The University of Texas MD Anderson Cancer Center have discovered a critical new factor in regulating phenylalanine metabolism and, therefore, in preventing the inherited metabolic disorder phenylketonuria (PKU).

5 Aug 2021

Research: Only 26% of areas in the UK have an effective pathway in place for early liver disease detection

New research published today in a peer review journal shows only 26% of areas in the UK have an effective pathway in place for the early detection of liver disease.

4 Aug 2021

Study shows safety and efficacy of radio-wave therapy for liver cancer patients

Researchers at Wake Forest School of Medicine have shown that a targeted therapy using non-thermal radio waves is safe to use in the treatment of hepatocellular carcinoma (HCC), the most common type of liver cancer.

30 Jul 2021

Drug combination could make curative surgery possible for some liver cancer patients

A combination of the kinase-inhibitor drug cabozantinib and the immunotherapy drug nivolumab can make curative surgery possible in some liver cancer patients who would normally not be considered surgery candidates.

29 Jul 2021

Two new proteins identified as therapeutic targets for preventing NAFLD and associated liver cancer

An international study led by the Lipids&Liver research team at the UPV/EHU-University of the Basque Country, the results of which have recently been published in the prestigious journal Cancer Research, has demonstrated that inhibiting either of the proteins E2F1 or E2F2 in the liver protects against the development of obesity-driven nonalcoholic fatty liver disease and its progression to cancer.

29 Jul 2021

Virginia Tech graduate student receives NSF grant to examine new treatments for pancreatic cancer

Jessica Gannon, a recent graduate in mechanical engineering at Virginia Tech, will continue her education and research as a doctoral student in biomedical engineering through Virginia Tech - Wake Forest University's School of Biomedical Engineering and Sciences.

19 Jul 2021

Study reveals how non-alcoholic fatty liver disease can develop into a life-threatening complication

Researchers revealed how non-alcoholic fatty liver disease can develop into a life-threatening complication.

13 Jul 2021

Specialized protein appears to regulate key step in cancer metastasis

Researchers have identified a specialized protein that appears to help prevent tumor cells from entering the bloodstream and spreading to other parts of the body.

12 Jul 2021

Shape of extracellular vesicles in body fluids could be a biomarker for identifying cancer types

A recent study by scientists from Japanese universities has shown that the shape of cell-derived nanoparticles, known as "extracellular vesicles" (EVs), in body fluids could be a biomarker for identifying types of cancer.

7 Jul 2021

University of Louisville receives NIH funding to support research into liver-related illness

The University of Louisville Hepatobiology and Toxicology Center of Biomedical Research Excellence has received $11.3 million in funding from the National Institutes of Health to support its research into liver-related illness for an additional five years.

21 Jun 2021

Experts call for more programs to help Aboriginal and Torres Strait Islander people with liver cancer

Rising numbers of liver cancer in Aboriginal and Torres Strait Islander communities has led experts at Flinders University to call for more programs, including mobile liver clinics and ultrasound in rural and remote Australia.

15 Jun 2021

British Liver Trust calls for action to address rising obesity rates that fuel liver disease crisis

The British Liver Trust is calling for greater awareness of a silent yet serious form of fatty liver disease, non-alcohol related steatohepatitis (NASH), as one million adults were reported to have been admitted to hospital with obesity-related conditions in 2020.

14 Jun 2021

Molecular subtype of cancer preferentially affects people with Indigenous ancestry

Oncotarget published "Global DNA hypermethylation pattern and unique gene expression signature in liver cancer from patients with Indigenous American ancestry" which reported that contrasting with this pattern, the age structure of HCC in Andean people displays a bimodal distribution with half of the patients developing HCC in adolescence and early adulthood.

2 Jun 2021

Liver Cancer News and Research

Further Reading

Research suggests potential new treatment strategy for phenylketonuria

Research: Only 26% of areas in the UK have an effective pathway in place for early liver disease detection

Study shows safety and efficacy of radio-wave therapy for liver cancer patients

Drug combination could make curative surgery possible for some liver cancer patients

Two new proteins identified as therapeutic targets for preventing NAFLD and associated liver cancer

Virginia Tech graduate student receives NSF grant to examine new treatments for pancreatic cancer

Study reveals how non-alcoholic fatty liver disease can develop into a life-threatening complication

Specialized protein appears to regulate key step in cancer metastasis

Shape of extracellular vesicles in body fluids could be a biomarker for identifying cancer types

University of Louisville receives NIH funding to support research into liver-related illness

Experts call for more programs to help Aboriginal and Torres Strait Islander people with liver cancer

British Liver Trust calls for action to address rising obesity rates that fuel liver disease crisis

Molecular subtype of cancer preferentially affects people with Indigenous ancestry

Researchers investigate link between the liver’s immune system composition and NASH pathology

Medicaid-Medicare partnership could cover lifesaving medications for hepatitis C

Combination approach can improve the success rate of cancer treatment

UCL scientists identify new immunotherapy to combat hepatitis B virus

New class of anti-cancer compounds effectively kills liver and breast cancer cells

Keyhole surgery for liver cancer results in better outcomes and quality of life

Combination of BMI and body shape predictor can help determine the risk of obesity-related cancers

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News